Frontlight ResearchEarly access
CompletedNo phase
Validation of a Risk Assessment Model for Postoperative Delirium Based on Artificial Intelligence
Key facts
- Who runs it
- University Hospital, Basel, Switzerland
- Where
- Switzerland3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 993 people enrolled
- Started
- 21 Nov 2022
- Ended
- 15 Jun 2024
- Type of study
- Observational
- Treatments tested
- Data collection on POD for calculation of the PIPRA score
- Record updated
- 18 December 2024
Who can take part
- Age
- 60 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Surgical patients ≥60 years old
- Planned postoperative hospital stay ≥ 2 days
- Consent from patient
Who cannot take part
- Intracranial surgery
- Surgery within the two previous weeks
- Cardiac surgery
- Preoperative delirium
- Insufficient knowledge in German or French
- Patient unable to consent
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Postoperative delirium (POD) is a frequent postoperative complication in the elderly, characterised by fluctuating disturbances in attention, awareness, and cognition. Identifying the patients at highest risk of developing POD was the aim of the artificial intelligence (AI)-based algorithm PIPRA. This prospective cohort study is to externally validate the AI-based PIPRA algorithm. The primary endpoint is the performance (AUC) of the PIPRA algorithm in predicting POD. The secondary endpoint is the performance (AUC) of the clinicians in predicting POD (and how it compares with the performance of the PIPRA algorithm).
Treatments tested
- Data collection on POD for calculation of the PIPRA score
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 18 December 2024